Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Am J Physiol Renal Physiol. 2019 Dec 1;317(6):F1450-F1461. doi: 10.1152/ajprenal.00246.2019. Epub 2019 Sep 30.
Diabetic kidney disease (DKD) is one of the leading pathological causes of decreased renal function and progression to end-stage kidney failure. To explore and characterize age-related changes in DKD and associated glomerular damage, we used a rat model of type 2 diabetic nephropathy (T2DN) at 12 wk and older than 48 wk. We compared their disease progression with control nondiabetic Wistar and diabetic Goto-Kakizaki (GK) rats. During the early stages of DKD, T2DN and GK animals revealed significant increases in blood glucose and kidney-to-body weight ratio. Both diabetic groups had significantly altered renin-angiotensin-aldosterone system function. Thereafter, during the later stages of disease progression, T2DN rats demonstrated a remarkable increase in renal damage compared with GK and Wistar rats, as indicated by renal hypertrophy, polyuria accompanied by a decrease in urine osmolarity, high cholesterol, a significant prevalence of medullary protein casts, and severe forms of glomerular injury. Urinary nephrin shedding indicated loss of the glomerular slit diaphragm, which also correlates with the dramatic elevation in albuminuria and loss of podocin staining in aged T2DN rats. Furthermore, we used scanning ion microscopy topographical analyses to detect and quantify the pathological remodeling in podocyte foot projections of isolated glomeruli from T2DN animals. In summary, T2DN rats developed renal and physiological abnormalities similar to clinical observations in human patients with DKD, including progressive glomerular damage and a significant decrease in renin-angiotensin-aldosterone system plasma levels, indicating these rats are an excellent model for studying the progression of renal damage in type 2 DKD.
糖尿病肾病(DKD)是导致肾功能下降和进展为终末期肾衰竭的主要病理原因之一。为了探索和描述与年龄相关的 DKD 及相关肾小球损伤的变化,我们使用了 12 周龄及以上的 2 型糖尿病肾病(T2DN)大鼠模型。我们将其与对照非糖尿病 Wistar 大鼠和糖尿病 Goto-Kakizaki(GK)大鼠的疾病进展进行了比较。在 DKD 的早期阶段,T2DN 和 GK 动物的血糖和肾脏/体重比显著增加。这两个糖尿病组的肾素-血管紧张素-醛固酮系统功能均发生了显著改变。此后,在疾病进展的后期阶段,与 GK 和 Wistar 大鼠相比,T2DN 大鼠的肾脏损伤显著增加,表现为肾脏肥大、多尿伴尿渗透压降低、高胆固醇血症、髓质蛋白管型大量出现以及严重的肾小球损伤。尿肾素脱落表明肾小球裂孔隔膜丢失,这也与高龄 T2DN 大鼠中白蛋白尿的急剧增加和 podocin 染色丢失相关。此外,我们还使用扫描离子显微镜形貌分析来检测和定量分析 T2DN 动物分离肾小球中足细胞突起的病理性重塑。总之,T2DN 大鼠出现了类似于人类 DKD 患者的肾脏和生理异常,包括进行性肾小球损伤和肾素-血管紧张素-醛固酮系统血浆水平的显著下降,表明这些大鼠是研究 2 型 DKD 肾脏损伤进展的优秀模型。